Stock Events

Stock Events

Search...

Protalix BioTherapeutics (PLX) Q4 2023 Earnings

14MarConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-0.07

0.02

0.12

0.21

Details

Expected EPS

-0.03

Actual EPS

-0.07

Surprise EPS

-0.04

Surprise Percent

+133.33%

Description

Protalix BioTherapeutics (PLX) has reported earnings of -0.07 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.